Axio Biosolutions Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 9

Axio Biosolutions General Information

Description

Developer of biomaterials-based medical devices designed to be used in pre-hospital, intra-operative, and post-operative clinical needs. The company's devices focus on the management of trauma, surgical, and chronic wounds by effectively managing exudates, pain reduction, and scar-less healing, enabling patients to heal from medical products that work on acute and chronic wounds.

Contact Information

Formerly Known As
Advamedica
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Supplies
Other Industries
Biotechnology
Corporate Office
  • Harvard Square, 1 Mifflin Place
  • Suite 400
  • Cambridge, MA 02138
  • United States
+1 (973) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Axio Biosolutions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Accelerator/Incubator 000.00 Completed Generating Revenue
7. Later Stage VC (Series B2) 27-Jul-2021 000 000.00 0000 Completed Generating Revenue
6. Later Stage VC (Series B1) 08-Jan-2020 00.00 000.00 000.00 Completed Generating Revenue
5. Accelerator/Incubator 01-Jun-2019 00.00 Completed Product In Beta Test
4. Later Stage VC (Series B) 26-Jan-2018 00.00 00.00 000.00 Completed Product In Beta Test
3. Later Stage VC (Series A) 09-May-2016 00.00 00.000 00.00 Completed Product In Beta Test
2. Seed Round 01-Jan-2010 $190K $190K 00000 Completed Startup
1. Grant 01-Jan-2009 $1M Completed Startup
To view Axio Biosolutions’s complete valuation and funding history, request access »

Axio Biosolutions Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B2 000,000 00.000000 0.000 00.00 00.00 00 00.00 00.000
Series B1 0,000,000 00.000000 0.000 00.00 00.00 00 00.00 00.000
Series B 1,966,700 $0.000010 0.01% $3.73 $3.73 1x $3.73 31.64%
Series A 781,367 $0.000010 0.01% $2.69 $2.69 1x $2.69 12.57%
To view Axio Biosolutions’s complete cap table history, request access »

Axio Biosolutions Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biomaterials-based medical devices designed to be used in pre-hospital, intra-operative, and post-operative
Medical Supplies
Cambridge, MA
3 As of 2024
000.00
000000000000 000.00

000000

e irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat n
0000000 00000000
Wilsonville, OR
00 As of 0000
00.000
000000000 - 00.000

0-0000

is nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
0000000 00000000
Wallingford, CT
000 As of 0000
0000 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Axio Biosolutions Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
RevMedx Venture Capital-Backed Wilsonville, OR 00 00.000 000000000 - 00.000
Z-Medica Formerly PE-Backed Wallingford, CT 000 000000&0
MedTrade Products Private Equity-Backed Crewe, United Kingdom 00 000.00 0000000 0000 000.00
Baxter International Corporation Deerfield, IL 00000 000.00 000000000 000.00
Ethicon Endo-Surgery Corporation Blue Ash, OH 0000
You’re viewing 5 of 5 competitors. Get the full list »

Axio Biosolutions Patents

Axio Biosolutions Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3111091-A1 Composite dressings, manufacturing methods and applications thereof Active 27-Aug-2018 000000000
CA-3111091-C Composite dressings, manufacturing methods and applications thereof Active 27-Aug-2018 000000000
US-20210252182-A1 Composite dressings, manufacturing methods and applications thereof Pending 27-Aug-2018 000000000
AU-2019331721-B2 Composite dressings, manufacturing methods and applications thereof Active 27-Aug-2018 000000000 0
AU-2019331721-A1 Composite dressings, manufacturing methods and applications thereof Active 27-Aug-2018 A61L15/28
To view Axio Biosolutions’s complete patent history, request access »

Axio Biosolutions Executive Team (5)

Name Title Board Seat Contact Info
Leo Mavely Founder, Chief Executive Officer, President & Chairman
Satish Jajodia Chief Financial Officer
Gourav Maheshwari Director of Finance & Board Member
You’re viewing 3 of 5 executive team members. Get the full list »

Axio Biosolutions Board Members (5)

Name Representing Role Since
Badri Pillapakkam Omidyar Network Board Member 000 0000
Barath Subramanian Accel Board Member 000 0000
Gourav Maheshwari Axio Biosolutions Director of Finance & Board Member 000 0000
Ranjith Menon Chiratae Ventures India Advisors Board Member 000 0000
Sameer Nath TrueScale Capital Board Member 000 0000
To view Axio Biosolutions’s complete board members history, request access »

Axio Biosolutions Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Axio Biosolutions Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
TrueScale Capital Venture Capital Minority 000 0000 000000 0
Omidyar Network Impact Investing Minority 000 0000 000000 0
University of California University Minority 000 0000 000000 0
MedTech Innovator Accelerator/Incubator Minority 000 0000 000000 0
RNT Associates Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »